UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C. 20549

                               FORM 8-K
                            CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
                     Date of Report: May 19, 2014


                      PEPTIDE TECHNOLOGIES, INC.
        (Exact name of registrant as specified in its charter)


      Nevada                 333-133347                        98-0479983
  (State or other       (Commission File Number)         (IRS Employer Number)
   jurisdiction of
   incorporation)

   601 Union Street, Two Union Square, 42nd Floor, Seattle, Washington 98101
   -------------------------------------------------------------------------
               (Address of Principal Executive Offices) (Zip Code)

                                 (206) 388-5498
               Registrant's telephone number, including area code

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))



                SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS

ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

On May 26, 2014,  Peptide  Technologies,  Inc.  entered into an exclusive global
distribution  agreement for its AquaNatural Marine coating with All-Sea Coatings
Ltd.  (a  division  of All-Sea  Enterprises)  of North  Vancouver,  Canada.  The
agreement with All-Sea  Coatings  provides a sales conduit and exclusive  rights
for  our   AquaNatural   Marine   coating  to  establish   all  aspects  of  the
commercialization of the first all natural and sustainable organic-based fouling
prevention  coatings  product  line to address the  economic  and  environmental
burden  of  aquatic  bio-fouling.  All-Sea  Coatings  will  be  responsible  for
deployment and  commercialization  of the AquaNatural Marine coating in both the
commercial and leisure marine  marketplace.  The AquaNatural Marine Coating is a
customizable  friction-reduction  paint formula for  stationary or mobile marine
assets for 5 years,  resulting in a potential fuel cost savings greater than 5%.
The  product  offers an  industry-first  successful  "30  MINUTE"  curing  phase
permitting significantly lower maintenance dry-dock downtime, and is designed to
prevent the attachment of fouling organisms to a wide variety of substrates.



















                                       2




                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this Report to be signed on its
behalf by the undersigned, hereunto duly authorized.

                                        PEPTIDE TECHNOLOGIES, INC.



                                        By: /s/ J. Erik Odeen
                                            ----------------------------------
                                             J. Erik Odeen
                                             CFO
Date: May 28, 2014